Atopic dermatitis (AD) is a common inflammatory skin disorder characterized by recurrent
eczematous lesions and intense itch. Although it most often starts in infancy and affects …

For centuries, itch was categorized as a submodality of pain. Recent research over the last
decade has led to the realization that itch is in fact a separate and distinct, albeit closely …

This guideline was developed as a joint interdisciplinary European project, including
physicians from all relevant disciplines as well as patients. It is a consensus‐based …

Despite the availability of several new systemic agents for psoriasis treatment, choosing the
right therapy in certain patient populations can be challenging. There are few up-to-date …

Background As an evidence resource for the currently planned European Academy of
Allergy and Clinical Immunology (EAACI) clinical practice guideline “systemic treatment of …

Atopic dermatitis (AD), one of the most common skin disorders seen in infants and children,
usually has its onset during the first 6 months of life. The prevalence of AD is similar in the …

Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of
children and 2% to 3% of adults. This guideline addresses important clinical questions that …

Background Many patients with moderate-to-severe atopic dermatitis (AD) require systemic
immunomodulating treatment to achieve adequate disease control. Objective We sought to …

The existing evidence for treatment of atopic eczema (atopic dermatitis, AE) is evaluated
using the national standard Appraisal of Guidelines Research and Evaluation. The …

Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with cutaneous
hyper-reactivity to environmental triggers that are innocuous to normal, non-atopic …